Core Laboratories Inc.
US ˙ NYSE ˙ US21867A1051

Introduction

This page provides a comprehensive analysis of the known insider trading history of Kevin Daniels. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Kevin Daniels has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
CAO & Treasurer 13,115
US:CLB / Core Laboratories Inc. CAO & Treasurer 11,024
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Kevin Daniels. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases CLB / Core Laboratories Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CLB / Core Laboratories Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLB / Core Laboratories Inc. Insider Trades
Insider Sales CLB / Core Laboratories Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CLB / Core Laboratories Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2019-03-11 CLB Daniels Kevin 428 66.2500 428 66.2500 28,355 366 10.9300 -23,677 -83.50
2018-08-14 CLB Daniels Kevin 73 112.6300 73 112.6300 8,222

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CLB / Core Laboratories Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Kevin Daniels as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2024-01-08 2023-12-31 4/A CLB Core Laboratories Inc. /DE/
Common Stock 		F - Taxes -2,834 13,115 -17.77 17.66 -50,048 231,611
2024-01-03 2023-12-31 4 CLB Core Laboratories Inc. /DE/
Common Stock 		M - Exercise 7,200 15,949 82.30
2024-01-03 2023-12-31 4 CLB Core Laboratories Inc. /DE/
Common Stock 		F - Taxes -2,769 13,180 -17.36 17.66 -48,901 232,759
2023-12-04 2023-12-01 4 CLB Core Laboratories Inc. /DE/
Common Stock 		M - Exercise 140 8,803 1.62
2023-12-04 2023-12-01 4 CLB Core Laboratories Inc. /DE/
Common Stock 		F - Taxes -54 8,749 -0.61 18.07 -976 158,094
2023-01-04 2022-12-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 6,000 11,024 119.43
2023-01-04 2022-12-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -2,361 8,663 -21.42 20.27 -47,857 175,599
2022-12-02 2022-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 140 5,080 2.83
2022-12-02 2022-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -56 5,024 -1.10 21.50 -1,204 108,016
2022-03-02 2022-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -120 280 -30.00
2022-03-02 2022-03-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 120 4,994 2.46
2022-03-02 2022-03-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -54 4,940 -1.08 27.51 -1,486 135,899
2022-02-17 2022-02-17 4 CLB CORE LABORATORIES N V
Performance Shares 		A - Award 9,500 9,500
2022-01-04 2021-12-31 4 CLB CORE LABORATORIES N V
Performance Shares 		M - Exercise -3,800 0 -100.00
2022-01-04 2021-12-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 3,800 6,370 147.86
2022-01-04 2021-12-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -1,496 4,874 -23.49 22.31 -33,376 108,739
2021-12-03 2021-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -140 400 -25.93
2021-12-03 2021-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 140 2,626 5.63
2021-12-03 2021-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -56 2,570 -2.13 22.41 -1,255 57,594
2021-07-06 2021-07-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -105 540 -16.28
2021-07-06 2021-07-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -48 2,486 -1.89 39.11 -1,877 97,227
2021-07-06 2021-07-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 105 2,534 4.32
2021-03-02 2021-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -120 645 -15.69
2021-03-02 2021-03-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -55 2,429 -2.21 36.84 -2,026 89,484
2021-03-02 2021-03-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 120 2,484 5.08
2021-02-23 2021-02-19 4 CLB CORE LABORATORIES N V
Performance Shares 		A - Award 7,200 7,200
2021-01-05 2020-12-31 4 CLB CORE LABORATORIES N V
Performance Shares 		M - Exercise -2,600 0 -100.00
2021-01-05 2020-12-31 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -1,024 2,364 -30.22 26.51 -27,146 62,670
2021-01-05 2020-12-31 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 2,600 3,388 329.95
2020-12-02 2020-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -140 765 -15.47
2020-12-02 2020-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -54 788 -6.41 23.20 -1,253 18,282
2020-12-02 2020-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 140 842 19.94
2020-07-02 2020-07-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -105 905 -10.40
2020-07-02 2020-07-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -47 702 -6.28 20.35 -956 14,286
2020-07-02 2020-07-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 105 749 16.30
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -70 1,010 -6.48
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -32 644 -4.73 9.49 -304 6,112
2020-04-02 2020-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 70 676 11.55
2020-03-03 2020-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -120 1,080 -10.00
2020-03-03 2020-03-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -54 606 -8.18 26.84 -1,449 16,265
2020-03-03 2020-03-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 120 660 22.22
2020-02-12 2020-02-11 4 CLB CORE LABORATORIES N V
Performance Shares 		A - Award 6,000 6,000
2019-12-03 2019-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -140 1,200 -10.45
2019-12-03 2019-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -54 540 -9.09 43.80 -2,365 23,652
2019-12-03 2019-12-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 140 594 30.84
2019-07-03 2019-07-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -105 1,340 -7.27
2019-07-03 2019-07-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -41 454 -8.28 52.88 -2,168 24,008
2019-07-03 2019-07-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 105 495 26.92
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -70 1,445 -4.62
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		F - Taxes -32 390 -7.58 68.93 -2,206 26,883
2019-04-02 2019-04-01 4 CLB CORE LABORATORIES N V
Common Shares 		M - Exercise 70 422 19.89
2019-03-12 2019-03-11 4 CLB CORE LABORATORIES N V
Common Shares 		S - Sale -428 352 -54.87 66.25 -28,355 23,320
2019-03-05 2019-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -120 1,515 -7.34
2019-03-05 2019-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -110 1,635 -6.30
2019-03-05 2019-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		F - Taxes -54 780 -6.47 67.37 -3,638 52,549
2019-03-05 2019-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise 120 834 16.81
2019-03-05 2019-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		F - Taxes -50 714 -6.54 67.37 -3,368 48,102
2019-03-05 2019-03-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise 110 764 16.82
2019-02-14 2019-02-12 4 CLB CORE LABORATORIES N V
Performance Shares 		A - Award 3,800 3,800
2018-12-04 2018-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -800 1,745 -31.43
2018-12-04 2018-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -140 2,545 -5.21
2018-12-04 2018-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		F - Taxes -308 654 -32.02 83.11 -25,598 54,354
2018-12-04 2018-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise 800 962 493.83
2018-12-04 2018-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		F - Taxes -54 162 -25.00 83.11 -4,488 13,464
2018-12-04 2018-12-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise 140 216 184.21
2018-09-05 2018-09-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -125 2,685 -4.45
2018-09-05 2018-09-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		F - Taxes -49 76 -39.20 114.55 -5,613 8,706
2018-09-05 2018-09-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise 125 125
2018-08-15 2018-08-14 4 CLB CORE LABORATORIES N V
Restricted Shares 		S - Sale -73 0 -100.00 112.63 -8,222
2018-07-03 2018-07-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise -105 2,810 -3.60
2018-07-03 2018-07-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		F - Taxes -32 73 -30.48 126.21 -4,039 9,213
2018-07-03 2018-07-01 4 CLB CORE LABORATORIES N V
Restricted Shares 		M - Exercise 105 105
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)